A phenomenological defense of sexual pharmakotherapy

Simple item page
dc.contributor.advisorParker, Emily
dc.contributor.authorLeach, Caitlin E.
dc.contributor.departmentTowson University. Department of Women's and Gender Studiesen_US
dc.date.accessioned2019-03-20T18:31:10Z
dc.date.available2019-03-20T18:31:10Z
dc.date.issued2019-03-11
dc.date.submitted2018-05
dc.description(M.S.) -- Towson University, 2018en_US
dc.description.abstractIn August 2015, the Food and Drug Administration approved flibanserin, a serotonin modulator, to treat hypoactive sexual desire disorder. Then, in November 2016, they approved prasterone, an intravaginal dehydroepiandrosterone suppository to treat pain upon intercourse. Utilizing different mechanisms of biochemically altering the body, these drugs are pharmaceutical attempts to improve the distress experienced by women lacking sexual desire. The pharmaceuticalization of feminine sexuality, then, is not inherently problematic. Rather, it is a biochemical attempt to change the relations among bodies, worlds, and desires. Admittedly, pharmaceutical approaches to women's sexuality have typically been reductionist, but a phenomenological deployment of pharmaceutical data need not proceed this way. Utilizing sociological studies of women's experiences of their sexuality and pharmacokinetic data, this paper seeks to lay the groundwork for a pharmakological phenomenology that recognizes the ambiguous biochemical changes induced by pharmaceuticals as having as much import for our lived experiences as the external world.en_US
dc.description.tableofcontentsClinical constructions of normal and pathological feminine sexuality -- Deconstructing normal and pathological feminine sexuality -- Toward a phenomenology of feminine sexuality -- From lived to living feminine sexuality
dc.formatapplication/pdf
dc.format.extentv, 65 pagesen_US
dc.genrehttp://library.towson.edu/digital/collection/etd/id/67831en_US
dc.genretheses
dc.identifierdoi:10.13016/m2ywnz-xqaa
dc.identifier.otherTSP2018Leach
dc.identifier.urihttp://hdl.handle.net/11603/13090
dc.language.isoen_USen_US
dc.relation.isAvailableAtTowson University
dc.titleA phenomenological defense of sexual pharmakotherapyen_US
dc.typeTexten_US

Files

Original bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
TSP2018Leach_Redacted.pdf
Size:
772.7 KB
Format:
Adobe Portable Document Format
Description:
Leach Thesis
Download
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.45 KB
Format:
Item-specific license agreed upon to submission
Description:
Download

Collections

Towson University Graduate Theses and Dissertations